ANI Pharmaceuticals Inc. Watch

from 8-K 20 pages Contingent Value Rights Agreement

from 8-K 37 pages [Dealer]1

from S-8 14 pages ANI Pharmaceuticals, Inc. Amended and Restated 2022 Stock Incentive Plan

from 8-K 13 pages Voting Agreement

from 8-K 4 pages ANI Pharmaceuticals, Inc. Amended and Restated 2022 Stock Incentive Plan Notice of Restricted Stock Grant

from 8-K 4 pages ANI Pharmaceuticals, Inc. Amended and Restated 2022 Stock Incentive Plan Notice of Restricted Stock Grant

from 10-Q 27 pages [***] Certain Information Contained in This Document Has Been Omitted Based on a Court Order. Assignment and Technology Transfer Agreement Between Biosante Pharmaceuticals, Inc. and Cold Genesys, Inc. Dated as of November 15, 2010 Assignment and Technology Transfer Agreement

from 10-K 9 pages Form of Indemnification Agreement

from 10-K 1 page Notice of Termination

from 10-K 3 pages Amendment to Agreement of Purchase and Sale

from 10-K 20 pages Article 1 Interpretation

from 10-K 2 pages Amendment No. 2024-2 to ANI Pharmaceuticals, Inc. Amended and Restated 2022 Stock Incentive Plan February 5, 2024

from 8-K 22 pages Article 1 Interpretation

from S-8 6 pages Amendment No. 2023-1 to ANI Pharmaceuticals, Inc. Amended and Restated 2022 Stock Incentive Plan Effective May 23, 2023

from 10-Q 45 pages Executive Employment Agreement

from 10-Q 46 pages Executive Employment Agreement

from 10-Q 47 pages ​ Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Such Excluded Information Has Been Marked With “[***].” ​ Asset Purchase Agreement ​ Between ​ Holmdel Pharmaceuticals, LP ​ and ​ ANI Pharmaceuticals, Inc. ​ Dated as of February 23, 2017 ​

from 10-Q 45 pages ​ Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Such Excluded Information Has Been Marked With “[***].” ​ Asset Purchase Agreement ​ Between ​ Cranford Pharmaceuticals, LLC ​ and ​ ANI Pharmaceuticals, Inc. ​ Dated as of February 23, 2017 ​

from 10-K 46 pages Executive Employment Agreement

from 10-K 25 pages Executive Employment Agreement Executive Employment Agreement (This “Agreement”) Between ANI Pharmaceuticals, Inc. (The “Company”) and Ori Gutwerg (“Executive”) Dated as of January 15, 2021. Each of the Company and Executive Are Sometimes Referred to Herein Individually as a “Party” and Together as the “Parties.” Whereas, the Company Wishes to Employ Executive, and Executive Wishes to Be Employed by the Company on the Terms and Conditions Set Forth Herein. Now, Therefore, in Consideration of the Mutual Promises, Terms, Covenants and Conditions Set Forth Herein and the Performance of Each, the Parties Hereto, Intending to Be Legally Bound, Hereby Agree as Follows: 1. Employment. (A)commencement Date. Executive Shall Commence Employment on February 1st, 2021, or Such Earlier or Later Date as the Parties May Agree (The Actual Date Executive Commences Employment, the “Commencement Date”)